[ Price : $8.95]
Pharmacyclics files a supplemental NDA for Imbruvica (ibrutinib) for front-line use in patients with chronic lymphocytic leukemia.[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 11/9: Drug Interactions with Hormonal Contraceptives (HCs): Public Health and ...[ Price : $8.95]
FDA accepts a Dimension Therapeutics IND for a clinical study to evaluate DTX101 in adult patients with moderate/severe to severe ...[ Price : $8.95]
Allergan gains FDA approval for three ANDAs for three generic Mucinex products.[ Price : $8.95]
FDAs Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee vote 23 to 1...[ Price : $8.95]
The Generic Pharmaceutical Association says FDA has no scientifically-supported safety or efficacy concern that would require it t...[ Price : $8.95]
Amgen submits a supplemental NDA seeking approval for a single-dosing option for monthly administration of Repatha (evolocumab) In...[ Price : $8.95]
FDA grants Aridis Pharmaceuticals a fast track designation for AR-301, a fully human anti-Staphylococcal alpha-toxin IgG1 monoclon...